Two Sigma Securities’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History
Bought
Maintained
Sold
Other funds holding FRLN
SP
EAM
CA
TAM
HCA
Two Sigma Securities's FRLN Position: Q4 2022 in Review
Two Sigma Securities sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2022, closing a stake of 792 shares — an estimated $8K sold.
Two Sigma Securities first reported a position in FRLN in Q3 2022 and held it in 1 quarter. The position peaked at $8K in Q3 2022. 17 funds tracked by Wall St. Rank hold FRLN as of Q4 2022.
- Two Sigma Securities reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
- Two Sigma Securities sold 792 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2022, an estimated $8K.
- Two Sigma Securities first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2022 and held it in 1 quarter.
- Two Sigma Securities's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $8K in Q3 2022.
- 17 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2022.
Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.